Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Center LaboratoriesROCO:4123 +0.79%71 Days Inventory is 124.88 as of Mar. 2026, which is 3% below its 10-year median of 128.42. GuruFocus rates ROCO:4123 with a GF Score™ of 71/100 and a GF Value™ of NT$44.47 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 921 Drug Manufacturers companies, Center Laboratories ranks better than 64.17% on this metric.
The historical rank and industry rank for Center Laboratories's Days Inventory or its related term are showing as below:
ROCO:4123'
s Days Inventory Range Over the Past 10 Years
Min: 84.33 Med: 128.42 Max: 169.11
Current: 127.66
During the past 13 years, Center Laboratories's highest Days Inventory was 169.11. The lowest was 84.33. And the median was 128.42.
ROCO:4123's Days Inventory is ranked better than 64.17% of 921
companies
in the Drug Manufacturers industry
Industry Median: 164.68
vs ROCO:4123: 127.66
Center Laboratories's Days Inventory
declined
from Mar. 2025 (128.85) to Mar. 2026 (124.88).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Center Laboratories's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.73.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Center Laboratories's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.73.
Center Laboratories (ROCO:4123) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Center Laboratories's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Center Laboratories's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Center Laboratories Days Inventory Related Terms
Center Laboratories Days Inventory Historical Data
* Premium members only.
The historical data trend for Center Laboratories's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Center Laboratories's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Center Laboratories Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Center Laboratories's Days Inventory distribution charts can be found below:
* The bar in red indicates where Center Laboratories's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Center Laboratories (ROCO:4123) has a Days Inventory of 124.88 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Center Laboratories and its competitors. This is near median its historical median of 128.42. Over the past decade, Center Laboratories' Days Inventory has ranged from 84.33 to 169.11. According to the industry distribution chart, Center Laboratories ranks #330 out of 921 companies in the Drug Manufacturers industry, placing it in the top 35.8%.
Is Center Laboratories' Days Inventory too high?
Center Laboratories' current Days Inventory of 124.88 is near median its 10-year median of 128.42. Over the past 10 years, this metric has ranged from a low of 84.33 to a high of 169.11. The Drug Manufacturers industry median Days Inventory is 164.68. Center Laboratories' value of 124.88 is 24.2% below this industry median. Based on the distribution chart, Center Laboratories ranks #330 out of 921 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Center Laboratories has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Center Laboratories' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Center Laboratories ranks #330 out of 921 companies for Days Inventory. This puts Center Laboratories in the upper half of its industry. The industry median Days Inventory is 164.68. Center Laboratories' value of 124.88 is 24.2% below this benchmark. Historically, Center Laboratories' own Days Inventory has ranged from 84.33 to 169.11 over the past decade. While the company's 10-year median is 128.42 vs. the industry median of 164.68, Center Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.68, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Center Laboratories's current Days Inventory of 124.88 is 24.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Center Laboratories and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Center Laboratories's current Days Inventory is 124.88, which is near median its own 10-year median of 128.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Center Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Center Laboratories (ROCO:4123) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$44.47, compared to a current price of NT$38.35 — trading 13.8% below its estimated fair value. The current Days Inventory is 124.88, which is near median its 10-year median of 128.42 and 24.2% below the Drug Manufacturers industry median of 164.68. Center Laboratories' overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Center Laboratories (ROCO:4123), the current Days Inventory is 124.88 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Center Laboratories (ROCO:4123) Overvalued in 2026?
Based on GuruFocus' analysis, Center Laboratories stock appears to be undervalued.
The current stock price of NT$38.35 is trading 13.8% below its estimated GF Value™ of NT$44.47.
GuruFocus considers Center Laboratories to be Modestly Undervalued.
Key valuation signals for ROCO:4123:
Days Inventory: 124.88 (near median its 10-year median of 128.42)
GF Value™: NT$44.47 vs. price of NT$38.35 (13.8% below fair value)
Industry Position: 24.2% below the Drug Manufacturers median (#330 of 921)
No single metric tells the full story. See the ROCO:4123 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Center Laboratories Inc is engaged in the manufacture and sale of various Western pharmaceuticals, including Western medicine manufacturing, wholesale, and retail. The Company operates through the following segments: Pharmaceutical Division, Biotechnology Venture Capital, and Glac Segment. The Pharmaceutical Division, which generates the majority of revenue, manufactures and sells various Western pharmaceuticals. The Biotechnology Venture Capital segment invests in domestic and foreign biotechnology undertakings, while the Glac Segment manufactures and sells probiotic products. The Company operates in Taiwan, Mainland China, and other regions, with Taiwan generating the majority of revenue.
71GF Score
Get the complete analysis for ROCO:4123
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4123 has been successfully added to your 
